Global Automated and Closed Cell Therapy Processing Systems Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Automated and Closed Cell Therapy Processing Systems market size will reach 1,539.84 Million USD in 2025 and is projected to reach 5,246.61 Million USD by 2032, with a CAGR of 19.14% (2025-2032). Notably, the China Automated and Closed Cell Therapy Processing Systems market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Automated and closed cell therapy processing systems are advanced technologies designed to streamline the manufacturing of cell-based therapies, such as CAR-T treatments or stem cell therapies, in a controlled and sterile environment. These systems integrate automated functions like cell isolation, expansion, washing, and cryopreservation, reducing the need for manual intervention and minimizing contamination risks. By maintaining a closed system, they ensure consistency, reproducibility, and compliance with stringent regulatory standards. Widely used in research and clinical applications, these systems enhance scalability and efficiency, enabling faster and more reliable production of personalized and regenerative medicine therapies.
The major global suppliers of Automated and Closed Cell Therapy Processing Systems include Cytiva, Miltenyi Biotec, Thermo Fisher Scientific, Terumo, Merck, Fresenius Kabi, Sartorius, Lonza, Boyalife (ThermoGenesis), EurekaBio, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Automated and Closed Cell Therapy Processing Systems. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Automated and Closed Cell Therapy Processing Systems market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Automated and Closed Cell Therapy Processing Systems market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Automated and Closed Cell Therapy Processing Systems industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Automated and Closed Cell Therapy Processing Systems Include:
Cytiva
Miltenyi Biotec
Thermo Fisher Scientific
Terumo
Merck
Fresenius Kabi
Sartorius
Lonza
Boyalife (ThermoGenesis)
EurekaBio
Automated and Closed Cell Therapy Processing Systems Product Segment Include:
Stem Cell Therapy
Non-Stem Cell Therapy
Automated and Closed Cell Therapy Processing Systems Product Application Include:
Academic Research
Biopharmaceuticals
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Automated and Closed Cell Therapy Processing Systems Industry PESTEL Analysis
Chapter 3: Global Automated and Closed Cell Therapy Processing Systems Industry Porter's Five Forces Analysis
Chapter 4: Global Automated and Closed Cell Therapy Processing Systems Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Automated and Closed Cell Therapy Processing Systems Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Automated and Closed Cell Therapy Processing Systems Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Automated and Closed Cell Therapy Processing Systems Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Automated and Closed Cell Therapy Processing Systems market size will reach 1,539.84 Million USD in 2025 and is projected to reach 5,246.61 Million USD by 2032, with a CAGR of 19.14% (2025-2032). Notably, the China Automated and Closed Cell Therapy Processing Systems market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Automated and closed cell therapy processing systems are advanced technologies designed to streamline the manufacturing of cell-based therapies, such as CAR-T treatments or stem cell therapies, in a controlled and sterile environment. These systems integrate automated functions like cell isolation, expansion, washing, and cryopreservation, reducing the need for manual intervention and minimizing contamination risks. By maintaining a closed system, they ensure consistency, reproducibility, and compliance with stringent regulatory standards. Widely used in research and clinical applications, these systems enhance scalability and efficiency, enabling faster and more reliable production of personalized and regenerative medicine therapies.
The major global suppliers of Automated and Closed Cell Therapy Processing Systems include Cytiva, Miltenyi Biotec, Thermo Fisher Scientific, Terumo, Merck, Fresenius Kabi, Sartorius, Lonza, Boyalife (ThermoGenesis), EurekaBio, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Automated and Closed Cell Therapy Processing Systems. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Automated and Closed Cell Therapy Processing Systems market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Automated and Closed Cell Therapy Processing Systems market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Automated and Closed Cell Therapy Processing Systems industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Automated and Closed Cell Therapy Processing Systems Include:
Cytiva
Miltenyi Biotec
Thermo Fisher Scientific
Terumo
Merck
Fresenius Kabi
Sartorius
Lonza
Boyalife (ThermoGenesis)
EurekaBio
Automated and Closed Cell Therapy Processing Systems Product Segment Include:
Stem Cell Therapy
Non-Stem Cell Therapy
Automated and Closed Cell Therapy Processing Systems Product Application Include:
Academic Research
Biopharmaceuticals
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Automated and Closed Cell Therapy Processing Systems Industry PESTEL Analysis
Chapter 3: Global Automated and Closed Cell Therapy Processing Systems Industry Porter's Five Forces Analysis
Chapter 4: Global Automated and Closed Cell Therapy Processing Systems Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Automated and Closed Cell Therapy Processing Systems Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Automated and Closed Cell Therapy Processing Systems Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Automated and Closed Cell Therapy Processing Systems Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Automated and Closed Cell Therapy Processing Systems Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Automated and Closed Cell Therapy Processing Systems Product by Type
- 1.2.1 Stem Cell Therapy
- 1.2.2 Non-Stem Cell Therapy
- 1.3 Automated and Closed Cell Therapy Processing Systems Product by Application
- 1.3.1 Academic Research
- 1.3.2 Biopharmaceuticals
- 1.4 Global Automated and Closed Cell Therapy Processing Systems Market Size Analysis (2020-2032)
- 1.5 Automated and Closed Cell Therapy Processing Systems Market Development Status and Trends
- 1.5.1 Automated and Closed Cell Therapy Processing Systems Industry Development Status Analysis
- 1.5.2 Automated and Closed Cell Therapy Processing Systems Industry Development Trends Analysis
- 2 Automated and Closed Cell Therapy Processing Systems Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Automated and Closed Cell Therapy Processing Systems Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Automated and Closed Cell Therapy Processing Systems Market Analysis by Country
- 4.1 Global Automated and Closed Cell Therapy Processing Systems Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Automated and Closed Cell Therapy Processing Systems Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Automated and Closed Cell Therapy Processing Systems Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.5 China Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.6 France Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.14 India Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Automated and Closed Cell Therapy Processing Systems Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Automated and Closed Cell Therapy Processing Systems Market Revenue by Key Suppliers (2021-2025)
- 5.2 Automated and Closed Cell Therapy Processing Systems Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Automated and Closed Cell Therapy Processing Systems Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Automated and Closed Cell Therapy Processing Systems Market Analysis by Type
- 6.1 Global Automated and Closed Cell Therapy Processing Systems Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Automated and Closed Cell Therapy Processing Systems Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Cytiva
- 7.1.1 Cytiva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Cytiva Automated and Closed Cell Therapy Processing Systems Product Portfolio
- 7.1.3 Cytiva Automated and Closed Cell Therapy Processing Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Miltenyi Biotec
- 7.2.1 Miltenyi Biotec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Miltenyi Biotec Automated and Closed Cell Therapy Processing Systems Product Portfolio
- 7.2.3 Miltenyi Biotec Automated and Closed Cell Therapy Processing Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Thermo Fisher Scientific
- 7.3.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Thermo Fisher Scientific Automated and Closed Cell Therapy Processing Systems Product Portfolio
- 7.3.3 Thermo Fisher Scientific Automated and Closed Cell Therapy Processing Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Terumo
- 7.4.1 Terumo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Terumo Automated and Closed Cell Therapy Processing Systems Product Portfolio
- 7.4.3 Terumo Automated and Closed Cell Therapy Processing Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Merck
- 7.5.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Merck Automated and Closed Cell Therapy Processing Systems Product Portfolio
- 7.5.3 Merck Automated and Closed Cell Therapy Processing Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Fresenius Kabi
- 7.6.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Fresenius Kabi Automated and Closed Cell Therapy Processing Systems Product Portfolio
- 7.6.3 Fresenius Kabi Automated and Closed Cell Therapy Processing Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Sartorius
- 7.7.1 Sartorius Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Sartorius Automated and Closed Cell Therapy Processing Systems Product Portfolio
- 7.7.3 Sartorius Automated and Closed Cell Therapy Processing Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Lonza
- 7.8.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Lonza Automated and Closed Cell Therapy Processing Systems Product Portfolio
- 7.8.3 Lonza Automated and Closed Cell Therapy Processing Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Boyalife (ThermoGenesis)
- 7.9.1 Boyalife (ThermoGenesis) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Boyalife (ThermoGenesis) Automated and Closed Cell Therapy Processing Systems Product Portfolio
- 7.9.3 Boyalife (ThermoGenesis) Automated and Closed Cell Therapy Processing Systems Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 EurekaBio
- 7.1
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
